Kaili Pan
Overview
Explore the profile of Kaili Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhuang Y, Wu K, Zhu X, Cai J, Hu S, Gao J, et al.
Front Oncol
. 2022 Jun;
12:911567.
PMID: 35747795
Clinical Trial Registration: http://www.chictr.org.cn/showproj.aspx?proj=10115, identifier ChiCTR-IPR-14005706.
2.
Yang W, Cai J, Shen S, Gao J, Yu J, Hu S, et al.
Lancet Oncol
. 2021 Jul;
22(9):1322-1332.
PMID: 34329606
Background: Vincristine plus dexamethasone pulses are generally used throughout maintenance treatment for childhood acute lymphoblastic leukaemia. However, previous studies remain inconclusive about the benefit of this maintenance therapy and the...
3.
Zheng H, Jiang H, Hu S, Liao N, Shen D, Tian X, et al.
J Clin Oncol
. 2021 Jun;
39(28):3161-3170.
PMID: 34077242
Purpose: Arsenic combined with all-trans retinoic acid (ATRA) is the standard of care for adult acute promyelocytic leukemia (APL). However, the safety and effectiveness of this treatment in pediatric patients...
4.
Xue Y, Chen J, Gao S, Zhai X, Wang N, Gao J, et al.
Sci Rep
. 2021 May;
11(1):9656.
PMID: 33958615
Tumor lysis syndrome (TLS) is a common and fatal complication of childhood hematologic malignancies, especially acute lymphoblastic leukemia (ALL). The clinical features, therapeutic regimens, and outcomes of TLS have not...
5.
Tang J, Yu J, Cai J, Zhang L, Hu S, Gao J, et al.
Blood
. 2021 Mar;
138(4):331-343.
PMID: 33684941
To identify the prognostic factors that are useful to improve central nervous system (CNS) control in children with acute lymphoblastic leukemia (ALL), we analyzed the outcome of 7640 consecutive patients...
6.
Zhu Y, Yang R, Cai J, Yu J, Tang Y, Chen Y, et al.
Cancer Med
. 2020 Jan;
9(6):2113-2121.
PMID: 31994344
Background: Septicemia is an important cause of treatment-related mortality and treatment failure in pediatric acute lymphoblastic leukemia (ALL) in developing countries. A multicenter CCCG-ALL-2015 study was conducted in China and...
7.
Shen S, Chen X, Cai J, Yu J, Gao J, Hu S, et al.
JAMA Oncol
. 2020 Jan;
6(3):358-366.
PMID: 31944221
Importance: A randomized clinical trial is needed to determine whether the second-generation Abl-tyrosine kinase inhibitor dasatinib is more effective than the first-generation inhibitor imatinib mesylate for childhood Philadelphia chromosome-positive acute...
8.
Cai J, Yu J, Zhu X, Hu S, Zhu Y, Jiang H, et al.
Arch Dis Child
. 2019 Feb;
104(6):522-529.
PMID: 30705079
Objectives: Before 2003, most children with acute lymphoblastic leukaemia (ALL) abandoned treatment, with only approximately 30% treated in China. With the development of national insurance for underprivileged patients, we assessed...
9.
Zhu H, Zhang X, He Y, Yu L, Lu Y, Pan K, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
. 2018 May;
32(1):104-111.
PMID: 29806374
Objective: To summarize the research progress on the source and selection of donor cells in the field of islet replacement therapy for diabetes mellitus. Methods: Domestic and abroad literature concerning...
10.
Zhu H, Li W, Liu Z, Li W, Chen N, Lu L, et al.
Tissue Eng Part B Rev
. 2017 Oct;
24(3):191-214.
PMID: 29048258
Pancreatic islet transplantation has been validated as a valuable therapy for type 1 diabetes mellitus patients with exhausted insulin treatment. However, this therapy remains limited by the shortage of donor...